Gyncentrum Sp. z o.o. — Clinical Trial Site

88 Registered trials

60 Currently recruiting

Organisation

Gyncentrum Sp. z o.o.

Location

Katowice, Poland

Identifier

ORG-100044129

Address

Ul. Zelazna 1, 40-851, Poland

Departments

-
#45001: NZOZ Holsamed- Oddzial Libero
#5703: Dermatology
2702: NZOZ Holsamed - Oddział Libero
4116: NZOZ Holsamed – Oddział Libero
505: NZOZ Holsamed - Oddzial Libero
Allergology
Badania Kliniczne
Clinical Trial
Dermatologia
Dermatology
Gyncentrum
Gyncentrum - Szpital
GynCentrum Sp. z o. o., NZOZ Holsamed - Oddział Liberoul.Kościuszki 229, 40-600 Katowice,Poland
Gyncentrum Sp. z o.o.
Gynecology
Gynocentrum
N/A
NA
NZOZ Gyncentrum
NZOZ GynCentrum - Oddzial Bielsko-Biala
NZOZ GynCentrum - Oddzial Czestochowa
NZOZ GynCentrum - Oddzial Krakow
NZOZ GynCentrum - Oddzial Poznan
NZOZ GynCentrum - Oddzial Warszawa
NZOZ GynCentrum - Oddzial Wroclaw
NZOZ GynCentrum - Oddział Bielsko-Biała
NZOZ Gyncentrum - Oddział Kraków
NZOZ GynCentrum - Oddział Warszawa
NZOZ GynCentrum – Oddział Warszawa
NZOZ Gyncentrum Oddział Warszawa
NZOZ Gyncentrum-Oddzial Warszawa
NZOZ Holsamed - Oddzial Libero
NZOZ Holsamed - Oddział Libero
NZOZ Holsamed - Odział Libero
NZOZ Holsamed – Oddział Libero
NZOZ Holsamed – Odział Libero
NZOZ Holsamed- Oddział Libero
NZOZ Holsamed-Oddzial Libero
NZOZ Holsamed-Oddział Libero
Oddzial Warszawa
Oddział Warszawa
POL05432: Dermatology
Psychiatry
TBC

Clinical trials at this site (88)

Search interface

Long-Term Extension Study (AtDvance) to Evaluate the Safety and Efficacy of GSK1070806 in Participants with Moderate to Severe Atopic Dermat… Ended

2023-508474-29-00 Dermatitis, Atopic 4 2024-10-30
A study on the immune response, safety and the occurrence of RSV-associated respiratory tract illness after administration of RSV OA vaccine… Ended

2023-509455-13-00 Respiratory Syncytial Virus Infections 11 2024-08-05
A study to assess and compare safety and tolerability of 3 months treatment with salbutamol administered via MDI containing propellant HFA-1… Ended

2023-509001-76-00 Asthma 5 2024-07-01
A Phase 2b, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Dose Finding study to evaluate the Efficacy, Safety, Pharmacokinet… Ended

2023-505414-15-00 Dermatitis, Atopic 4 2024-04-10
This is a clinical trial (study), to be conducted at multiple clinical sites, of an oral study drug (EP262) that will be investigated in adu… Ended

2023-504799-94-00 Chronic Spontaneous Urticaria 4 2024-02-20
This is a clinical trial (study), to be conducted in several clinical sites worldwide, of an oral study drug which will be investigated in a… Ended

2023-503957-36-00 Moderate-to-Severe pruritus in adult subjects with nota 10 2023-12-04
BP11 Versus EU-Approved Xolair® in Patients With Chronic Spontaneous Urticaria Ended

2024-514764-72-00 Chronic Urticaria 5 2023-09-27
A double-blind, randomised, dose-finding trial to assess the efficacy, safety and pharmacokinetics of a single dose of albaconazole versus f… Ended

2023-504727-32-00 Acute vulvovaginal candidiasis 4 2023-09-18
A multicentre, single arm trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 1… Ended

2022-502023-21-00 Prevention of pregnancy 5 2023-07-12
A pivotal, multicentre, randomised, open-label, parallel-group trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgest… Ended

2022-502024-51-00 Prevention of pregnancy 5 2023-07-12
A 2-year Open-label Extension Study to Assess the Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Patients with Modera… Ended

2022-502575-30-00 Atopic Dermatitis 5 2023-05-23
Phase 3, 52-week Study Evaluating Rocatinlimab (AMG451)in Adolescent Subjects With Moderate-to-severe AD (ROCKET-ASTRO) Ended

2022-501586-50-00 Atopic Dermatitis 5 2023-05-15
Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab (AMG 451) in Combination with Topical Corticosteroids and/or Topical … Ended

2022-501585-22-00 Atopic Dermatitis 5 2023-05-11
The efficacy and the safety of two doses of CHF6001 for the treatment of Chronic Obstructive Pulmonary Disease (COPD) Ended

2023-510175-60-00 Chronic obstructive pulmonary disease (COPD) and Chron 5 2021-06-16
CHRONOS - A study to learn about the effects and safety of ODM-111 in participants with long-lasting pain due to osteoarthritis of the knee. Ended

2024-513553-79-00 Chronic Pain due to Ostheoarthritis of the knee 4
Dose-ranging study evaluating the efficacy and safety of EVO756 in adults with Chronic Spontaneous Urticaria. Ended

2024-518786-10-01 Moderate to Severe Chronic Spontaneous Urticaria 4